BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15077479)

  • 1. [Neurofibromatosis type 1 in children--with special consideration of ophthalmologic symptoms].
    Kósa E; Csákváry V
    Orv Hetil; 2004 Feb; 145(9):473-8. PubMed ID: 15077479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurofibromatosis type 1: a survey of 195 patients].
    Overweg-Plandsoen WC; Weersink RG; Sillevis Smitt JH; Fleury P; van Asperen CJ
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):624-9. PubMed ID: 9127578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurofibromatosis type 1--own experiences].
    Czajkowski G; Kałuzny J; Jatczak-Gaca A; Wysocki M
    Klin Oczna; 2010; 112(1-3):45-8. PubMed ID: 20572503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eye disorders in neurofibromatosis (NF1).
    Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
    Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophthalmological manifestations in segmental neurofibromatosis type 1.
    Ruggieri M; Pavone P; Polizzi A; Di Pietro M; Scuderi A; Gabriele A; Spalice A; Iannetti P
    Br J Ophthalmol; 2004 Nov; 88(11):1429-33. PubMed ID: 15489488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurofibromatosis in children. Our experience].
    López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
    Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis type 1 in childhood].
    Kongshaug N; Meyer B; Kolmannskog S
    Tidsskr Nor Laegeforen; 1999 Aug; 119(18):2653-7. PubMed ID: 10479978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic significance of unilateral Lisch nodules.
    Ceuterick SD; Van Den Ende JJ; Smets RM
    Bull Soc Belge Ophtalmol; 2005; (295):49-53. PubMed ID: 15849989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis and the most frequent symptoms of neurofibromatosis type 1].
    Czajkowski G; Kałuzny J; Jatczak-Gaca A; Wysocki M
    Klin Oczna; 2009; 111(10-12):378-83. PubMed ID: 20169901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ophthalmological manifestations of Von Recklinghausen disease].
    Benchekroun O; Lamari H; Moutawakkil A; Laouissi N; Zaghloul K; Amraoui A
    J Fr Ophtalmol; 1997; 20(10):753-7. PubMed ID: 9587589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lisch nodules. Markers for a non-invasive diagnosis in Recklinghausen neurofibromatosis].
    Crişan M; Talu S; Florea M; Coprean D; Cosgarea R; Crişan D
    Oftalmologia; 2008; 52(4):56-61. PubMed ID: 19354164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
    Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
    Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurofibromatosis type 1 and hypertension in pediatrics: case report].
    Demarchi I; Genoni G; Prodam F; Petri A; Busti A; Cortese L; Negro M; Bellone S; Acucella G; Bona G
    Minerva Pediatr; 2011 Aug; 63(4):335-9. PubMed ID: 21909069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of spheno-orbital dysplasia with plexiform neuroma in von Recklinghausen's neurofibromatosis].
    Khairallah M; Messaoud R; Ladjimi A; Hmidi K; Chaouch K
    J Fr Ophtalmol; 1999 Nov; 22(9):975-8. PubMed ID: 10609174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of optic pathway glioma screening in young children with neurofibromatosis type I: questions generated by a clinical audit.
    Pilling RF; Lloyd IC; Huson S
    Eye (Lond); 2010 Oct; 24(10):1603-5. PubMed ID: 20689568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
    Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
    Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical study of type 1 neurofibromatosis in north west England.
    McGaughran JM; Harris DI; Donnai D; Teare D; MacLeod R; Westerbeek R; Kingston H; Super M; Harris R; Evans DG
    J Med Genet; 1999 Mar; 36(3):197-203. PubMed ID: 10204844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.